Incannex Healthcare (IXHL) Gains from Investment Securities (2023 - 2026)
Incannex Healthcare's (IXHL) quarterly Gains from Investment Securities came in at $3939.0 in Q1 2026, down 98.32% year-on-year from $235008.0 in Q1 2025, and down 96.67% quarter-over-quarter from $118173.0 in Q4 2025.
Incannex Healthcare (IXHL) Gains from Investment Securities (2023 - 2026) Analysis & Trends
Incannex Healthcare has disclosed Gains from Investment Securities across 4 years of filings, most recently posting $3939.0 for Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $3939.0, down 98.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $3939.0 (down 98.32% YoY), and the FY2025 annual result was $3939.0, down 48.06% from the prior year.
- Gains from Investment Securities came in at $3939.0 for Q1 2026 at Incannex Healthcare, down from $118173.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $2.8 million in Q2 2025 to a low of $3939.0 in Q1 2026.
- The 4-year median for Gains from Investment Securities is $235008.0 (2024), against an average of $473992.4.
- Across the five-year window, Gains from Investment Securities plunged 98.8% in 2024 and jumped 36411.08% in 2025, its largest moves.
- Incannex Healthcare's Gains from Investment Securities stood at $349500.0 in 2023, then tumbled by 32.76% to $235008.0 in 2024, then plunged by 49.72% to $118173.0 in 2025, then sank by 96.67% to $3939.0 in 2026.
- The last three Gains from Investment Securities figures came in at $3939.0 (Q1 2026), $118173.0 (Q4 2025), and $118173.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Incannex Healthcare | 48.16 Mn | 48.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,939.00 |
| Mar 31, 2026 | 3,939.00 |
| Dec 31, 2025 | 118,173.00 |
| Dec 31, 2025 | 118,173.00 |
| Sep 30, 2025 | 118,173.00 |
| Sep 30, 2025 | 118,173.00 |
| Jun 30, 2025 | 2.77 Mn |
| Jun 30, 2025 | 2.77 Mn |
| Mar 31, 2025 | 235,008.00 |
| Mar 31, 2025 | 235,008.00 |
| Dec 31, 2024 | 235,008.00 |
| Dec 31, 2024 | 235,008.00 |
| Sep 30, 2024 | 235,008.00 |
| Sep 30, 2024 | 235,008.00 |
| Jun 30, 2024 | 7,584.00 |
| Jun 30, 2024 | 7,584.00 |
| Mar 31, 2024 | 349,500.00 |
| Mar 31, 2024 | 349,500.00 |
| Dec 31, 2023 | 349,500.00 |
| Dec 31, 2023 | 349,500.00 |